171 related articles for article (PubMed ID: 20702830)
1. Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.
Piña Y; Houston SK; Murray TG; Boutrid H; Celdran M; Feuer W; Shi W; Hernandez E; Lampidis TJ
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6149-56. PubMed ID: 20702830
[TBL] [Abstract][Full Text] [Related]
2. Targeting hypoxia, a novel treatment for advanced retinoblastoma.
Boutrid H; Jockovich ME; Murray TG; Piña Y; Feuer WJ; Lampidis TJ; Cebulla CM
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2799-805. PubMed ID: 18326690
[TBL] [Abstract][Full Text] [Related]
3. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
Jockovich ME; Murray TG; Escalona-Benz E; Hernandez E; Feuer W
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1264-8. PubMed ID: 16565356
[TBL] [Abstract][Full Text] [Related]
4. Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
Boutrid H; Piña Y; Cebulla CM; Feuer WJ; Lampidis TJ; Jockovich ME; Murray TG
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5537-43. PubMed ID: 19578014
[TBL] [Abstract][Full Text] [Related]
5. Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
Piña Y; Decatur C; Murray TG; Houston SK; Lopez-Cavalcante M; Hernandez E; Celdran M; Shah N; Feuer W; Lampidis T
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):996-1002. PubMed ID: 22266512
[TBL] [Abstract][Full Text] [Related]
6. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Van Quill KR; Dioguardi PK; Tong CT; Gilbert JA; Aaberg TM; Grossniklaus HE; Edelhauser HF; O'Brien JM
Ophthalmology; 2005 Jun; 112(6):1151-8. PubMed ID: 15885791
[TBL] [Abstract][Full Text] [Related]
7. Subconjunctival carboplatin in retinoblastoma: impact of tumor burden and dose schedule.
Hayden BH; Murray TG; Scott IU; Cicciarelli N; Hernandez E; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2000 Nov; 118(11):1549-54. PubMed ID: 11074812
[TBL] [Abstract][Full Text] [Related]
8. Subconjunctival nanoparticle carboplatin in the treatment of murine retinoblastoma.
Kang SJ; Durairaj C; Kompella UB; O'Brien JM; Grossniklaus HE
Arch Ophthalmol; 2009 Aug; 127(8):1043-7. PubMed ID: 19667343
[TBL] [Abstract][Full Text] [Related]
9. Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.
Houston SK; Piña Y; Murray TG; Boutrid H; Cebulla C; Schefler AC; Shi W; Celdran M; Feuer W; Merchan J; Lampidis TJ
Clin Ophthalmol; 2011 Jan; 5():129-37. PubMed ID: 21339806
[TBL] [Abstract][Full Text] [Related]
10. Iontophoretic delivery of carboplatin in a murine model of retinoblastoma.
Hayden B; Jockovich ME; Murray TG; Kralinger MT; Voigt M; Hernandez E; Feuer W; Parel JM
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3717-21. PubMed ID: 16936078
[TBL] [Abstract][Full Text] [Related]
11. Focal periocular carboplatin chemotherapy avoids systemic chemotherapy for unilateral, progressive retinoblastoma.
Leng T; Cebulla CM; Schefler AC; Murray TG
Retina; 2010 Apr; 30(4 Suppl):S66-8. PubMed ID: 20419851
[TBL] [Abstract][Full Text] [Related]
12. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
13. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma.
Suárez F; Jockovich ME; Hernandez E; Feuer W; Parel JM; Murray TG
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3437-40. PubMed ID: 17652710
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
Schaiquevich P; Ceciliano A; Millan N; Taich P; Villasante F; Fandino AC; Dominguez J; Chantada GL
Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
[TBL] [Abstract][Full Text] [Related]
16. External beam radiation "salvage" therapy in transgenic murine retinoblastoma.
Sobrin L; Hayden BC; Murray TG; Cicciarelli N; Scott IU; Hernandez E; Wu X; Markoe AM; Feuer W; Fulton L; O'Brien JM
Arch Ophthalmol; 2004 Feb; 122(2):251-7. PubMed ID: 14769602
[TBL] [Abstract][Full Text] [Related]
17. Subconjunctival carboplatin therapy and cryotherapy in the treatment of transgenic murine retinoblastoma.
Murray TG; Cicciarelli N; O'Brien JM; Hernández E; Mueller RL; Smith BJ; Feuer W
Arch Ophthalmol; 1997 Oct; 115(10):1286-90. PubMed ID: 9338675
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model.
Jockovich ME; Suarez F; Alegret A; Piña Y; Hayden B; Cebulla C; Feuer W; Murray TG
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5371-6. PubMed ID: 18055783
[TBL] [Abstract][Full Text] [Related]
20. Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors.
Piña Y; Decatur C; Murray T; Houston S; Gologorsky D; Cavalcante M; Cavalcante L; Hernandez E; Celdran M; Feuer W; Lampidis T
Clin Ophthalmol; 2011; 5():337-43. PubMed ID: 21468343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
